Posted inDiabetes & Endocrinology news
Belatacept and Sirolimus Show Promise as Safer Immunosuppression in Islet Transplantation for Type 1 Diabetes
A multi-centre phase 2 study demonstrates that belatacept combined with sirolimus achieves superior islet transplant outcomes with better renal preservation compared to conventional tacrolimus-based therapy in type 1 diabetes patients.